Beta-adrenergic Receptor -

While commonly used for heart conditions, beta-blockers have been found to act as proinflammatory agents in the brain, with research in PMC7686098 indicating that they impair microglia-mediated phagocytosis of synaptic material, increasing neuroinflammation. Chronic Heart Failure (CHF): β1beta sub 1

-ARs are key regulators in embryonic development. They modulate actomyosin relaxation, allowing epithelial tissues to stretch during body elongation, as detailed in Cell.com . 4. Summary of Subtype Characteristics Primary Location Key Physiological Effect β1beta sub 1 Heart, Adipose tissue Increases heart rate & contractility β2beta sub 2 Smooth muscle (Airways), Immune Cells Bronchodilation, Vasodilation β3beta sub 3 Adipose tissue, Urinary bladder Lipolysis, Thermogenesis

with specific beta-blockers, allowing for state-specific modeling (active vs. inactive). 2. Emerging Roles in Disease Pathogenesis -adrenergic signaling (specifically beta-adrenergic receptor

activity can lower the risk of heart failure, confirming the efficacy of beta-blocker therapies. 3. Developmental Biology Roles

-AR activation) increases cancer cell stiffness, enhancing mobility and promoting metastasis. Studies have shown that blocking ARs can attenuate lung metastasis in various cancer models. While commonly used for heart conditions, beta-blockers have

Contrary to their primary role in the adult nervous system, β2beta sub 2

Beta2-Receptor Agonists and Antagonists - StatPearls - NCBI - NIH Immune Cells Bronchodilation

Are you researching their role in a specific disease, like ?